News list for " harm"
Harmonic, an AI startup co-founded by Robinhood CEO Vlad Tenev, has raised $120 million at a valuation of $1.45 billion, led by Ribbit Capital with participation from Sequoia, Kleiner Perkins and new investor Emerson Collective. Harmonic's core technology, Mathematical Superintelligence (MSI), is based on formal logic rather than statistical prediction and is designed to solve the AI illusion problem. Its flagship model, Aristotle, outperformed Google in the International Mathematical Olympiad.
Robinhood CEO Vlad Tenev 联合创立的 AI 初创公司 Harmonic 完成 1.2 亿美元融资，估值达 14.5 亿美元。本轮融资由 Ribbit Capital 领投，Sequoia、Kleiner Perkins 和新投资方 Emerson Collective 参投。 Harmonic 核心技术“数学超级智能 (MSI)”基于形式逻辑而非统计预测，旨在解决 AI 幻觉问题。其旗舰模型 Aristotle 在国际数学奥林匹克竞赛中表现优异，达到与谷歌...
Quantum BioPharma (NASDAQ: QNTM) today announced financial results for the third quarter of 2025, showing a significant strengthening of the company's finances, with a 275% sequential increase in shareholders' equity, a 50% reduction in total liabilities, and an 87% decrease in debt-to-equity ratio. The company's digital asset portfolio, primarily bitcoin, has realized $572,000 in gains, and total digital assets have increased from $800,000 at the end of 2024 to $5.20 million today.
Quantum BioPharma（纳斯达克股票代码：QNTM）今日公布2025年第三季度财务业绩，显示公司财务状况显著增强，股东权益环比增长275%，总负债减少50%，债务权益比率下降87%。公司数字资产组合（主要为比特币）已实现57.2万美元收益，数字资产总额从2024年底的80万美元增至当前520万美元。
Solana infrastructure startup Harmonic announced the completion of a $6 million seed round led by Paradigm, which is also said to include angel investment from unidentified "key Solana stakeholders", but the specific investor information has not been disclosed.
Solana 基础设施初创公司 Harmonic 宣布完成 600 万美元种子轮融资，Paradigm 领投，据悉此轮融资还包括来自未公开身份的“Solana 关键利益相关者”的天使投资，但具体投资方信息暂未披露。
On November 4th, according to Globenewswire, digital asset finance company Propanc Biopharma (NASDAQ: PPCB) announced a strategic plan to acquire digital asset management (DAT) companies that are currently trading below their market capitalization-to-net asset value (MNAV) ratios. Company management believes that the acquisition of undervalued digital asset technology (DAT) companies is a way to strengthen Propanc's balance sheet, diversify its assets and create long-term stocks...
11月4日消息，据Globenewswire报道，数字资产财务公司Propanc Biopharma（纳斯达克股票代码：PPCB）宣布了一项战略计划，旨在收购目前市值与净资产值之比（MNAV）低于其交易的数字资产管理（DAT）公司。公司管理层认为，收购被低估的数字资产技术（DAT）公司是增强Propanc资产负债表、实现资产多元化并创造长期股...
On October 15th, Propanc Biopharma, a biopharmaceutical company that adopts the Ethereum treasury strategy, announced a strategic financing agreement of up to $100 million with the family office Hexstone Capital. Propanc CEO James Nathanielsz said that the financing will accelerate the development of the company's clinical pipeline and plans to grow the value of the digital asset library to $100 million or more in the next 12 months. Hexstone Capital has previously invested in several companies ...
10 月 15 日消息，采用以太坊财库战略的生物制药公司 Propanc Biopharma 宣布与家族办公室 Hexstone Capital 达成最高 1 亿美元的战略融资协议。 Propanc CEO James Nathanielsz 表示，此次融资将加速公司临床管线开发，并计划在未来 12 个月内将数字资产库价值增长至 1 亿美元或以上。Hexstone Capital 此前已投资多家拥有数字资产库的公司，涉及 BTC、ETH、SOL、DOGE 等多种数字资产。 此前消息，九月初...
